drugset / Trial / NCT02403284
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
RandomizedCrossoverQuadruple-blindBasic science
Summary
In this research study, investigators will test the effects of an approved medication for diabetes,Liraglutide, to reduce insulin resistance that develops from eating a diet high in saturated fats.
Timeline
- Start
- 2013-03
- Primary completion
- 2021-04-28
- Completion
- 2023-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liraglutide | Peptide | 1.8 mg | Subcutaneous |
Indications
No indication recorded.